This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tune, J. D. Articles by Feigl, E. O. Search for Related Content PubMed PubMed Citation Articles by Tune, J. D. Articles by Feigl, E. O. Related Collections Coronary circulation Endothelium/vascular type/nitric oxide

(Circulation. 2000;101:2942.)
© 2000 American Heart Association, Inc.

Basic Science Reports

Role of Nitric Oxide and Adenosine in Control of Coronary Blood Flow in Exercising Dogs

Johnathan D. Tune, PhD; Keith Neu Richmond, PhD; Mark W. Gorman, PhD; Eric O. Feigl, MD

From the Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle.

Correspondence to Eric O. Feigl, MD, Department of Physiology and Biophysics, University of Washington School of Medicine, Box 357290, Seattle, WA 98195-7290.

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background—Inhibition of nitric oxide (NO) synthesis results in very little change in coronary blood flow, but this is thought to be because cardiac adenosine concentration increases to compensate for the loss of NO vasodilation. Accordingly, in the present study, adenosine measurements were made before and during NO synthesis inhibition during exercise.

Methods and Results—Experiments were performed in chronically instrumented dogs at rest and during graded treadmill exercise before and during inhibition of NO synthesis with N-nitro-L-arginine (L-NNA, 35 mg/kg IV). Before inhibition of NO synthesis, myocardial oxygen consumption increased 3.7-fold, and coronary blood flow increased 3.2-fold from rest to the highest level of exercise, and this was not changed by NO synthesis inhibition. Coronary venous oxygen tension was modestly reduced by L-NNA at all levels of myocardial oxygen consumption. However, the slope of the relationship between myocardial oxygen consumption and coronary venous oxygen tension was not altered by L-NNA. Inhibition of NO synthesis did not increase coronary venous plasma or estimated interstitial adenosine concentration. During exercise, estimated interstitial adenosine remained well below the threshold concentration necessary for coronary vasodilation before or after L-NNA.

Conclusions—NO causes a modest coronary vasodilation at rest and during exercise but does not act as a local metabolic vasodilator. Adenosine does not mediate a compensatory local metabolic coronary vasodilation when NO synthesis is inhibited.

Key Words: nitric oxide • adenosine • coronary disease • exercise

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Although nitric oxide (NO) is thought to be one of the factors controlling coronary blood flow, the inhibition of NO synthesis with arginine analogues results in either no change^{1 2 3 4 5 6 7 8 9 10 11} or a small decrease^{12 13 14 15 16} in coronary blood flow at rest or when myocardial oxygen consumption is elevated. Previous studies have also shown that coronary venous oxygen tension, a sensitive indicator of the match between coronary blood flow and myocardial metabolism, is only modestly decreased when NO synthesis is inhibited.^{1 2 6} A proposed explanation for the modest decrease in coronary blood flow and coronary venous oxygen tension is that there is an increase in adenosine levels that compensates for the loss of NO-mediated coronary vasodilation. This explanation is supported by experiments in which either coronary venous adenosine concentration and/or adenosine release was augmented after inhibition of NO synthesis.^{15 17}

Adenosine receptor blockade has also been used in combination with NO synthesis inhibition in this context. A decrease in coronary blood flow after adenosine receptor blockade was interpreted as a compensatory adenosine coronary vasodilation after NO synthesis inhibition.^{15 18} However, this was not observed in all studies.^{6 14 17}

The present study was designed to examine the role of adenosine in local metabolic control of coronary blood flow when NO synthesis is inhibited. Experiments were performed in chronically instrumented dogs at rest and during graded treadmill exercise with and without inhibition of NO synthesis with N-nitro-L-arginine (L-NNA). Interstitial adenosine concentration was estimated from arterial and coronary venous measurements by using a previously described, axially distributed, mathematical model.^{19 20} The present results indicate that NO contributes modestly to matching coronary blood flow with myocardial oxygen consumption at rest and during exercise but that adenosine does not increase to mediate coronary vasodilation when NO synthesis is inhibited.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
General Preparation
Experiments were performed on 10 adult male mongrel dogs (weighing 23 to 37 kg) taught to run on a treadmill. The surgical procedures performed in the present study were previously described by Tune et al.²¹ Briefly, a splenectomy was performed, and a catheter was placed in the descending thoracic aorta to measure aortic blood pressure and to obtain arterial blood samples. A second catheter was placed in the coronary sinus via the right atrial appendage for coronary venous blood sampling. A flow transducer was placed around the circumflex artery.

At the time of the experiment, a catheter-tip pressure transducer (Millar Instruments) was inserted into the aortic catheter to measure blood pressure.²¹ Coronary blood flow was measured with an ultrasonic flow transducer (Transonics) and normalized per gram of perfused myocardium.²¹ Blood gas values were determined with an Instrumentation Laboratories 1306 analyzer. Oxygen content was determined by using the fuel-cell method (Total O₂X, Hospex), and lactate concentration was determined with a YSI model 1500 lactate analyzer.

Plasma Adenosine Measurement and Estimation of Cardiac Interstitial Adenosine Concentration
Adenosine measurements were made as previously described.²¹ Briefly, blood samples were immediately mixed with an ice-cold enzymatic stop solution. After immediate centrifugation, the supernatant was deproteinated and purified on C-18 Sep-Pak cartridges. Each sample was divided into 2 aliquots, and adenosine deaminase (0.1 U, Boehringer) was added to 1 of the aliquots, which was used as a paired blank for high-performance liquid chromatography (Hewlett Packard 1100).

Cardiac interstitial adenosine concentration was estimated by use of a 4-region (plasma, endothelial cell, interstitial space, and parenchymal cell) axially distributed mathematical model as previously described.^{19 20 22}

Exercise Protocol
The hypothesis that adenosine increases to mediate coronary vasodilation when NO synthesis is inhibited was examined at rest and during graded treadmill exercise with 2 treatments: (1) control vehicle (n=10) and (2) L-NNA (n=10). Each animal served as its own control, and the animals were allowed at least 2 days of recovery between experiments. The dose of L-NNA (35 mg/kg IV) used in this investigation was previously found to reduce vasodilation to acetylcholine by >60% in conscious dogs.^{2 9 11} The L-NNA was dissolved in 120 mL of 0.9% saline and was infused intravenously over 10 minutes

Statistical Analyses
Data are presented as mean±SEM. Multiple linear regression was used to compare slopes for the 2 treatments when a response variable was plotted versus myocardial oxygen consumption (SAS). ANCOVA was used to adjust a response variable for linear dependence on myocardial oxygen consumption after testing for parallel regression lines (SAS). The Table presents means by exercise level and does not include probability values because the probability values pertain to the overall treatment effects, as shown in the figures.

View this table: [in this window] [in a new window]   Table 1. Hemodynamic and Metabolic Variables at Rest and During Graded Treadmill Exercise

	Results

Top Abstract Introduction Methods Results Discussion References

 
Hemodynamic and metabolic data for the 10 dogs are given in the Table. Resting values before drug or vehicle administration are presented in the Table but were not included in the statistical analysis of drug and exercise effects. In the control group, myocardial oxygen consumption increased 3.7-fold, and coronary blood flow increased 3.2-fold from rest to the highest level of exercise (Figure 1A). Blockade of NO synthesis with L-NNA did not attenuate the coronary flow response to exercise, but the slope of the coronary blood flow versus myocardial oxygen consumption relationship was significantly increased (P=0.01). The increased slope with L-NNA treatment was likely due to the lower hematocrit (Table) and does not reflect a potentiation of coronary blood flow when NO synthesis is inhibited. The probable reason that the hematocrit was lower during the L-NNA experiments was that the L-NNA experiments were performed after the control experiments, and blood sampling lowered the hematocrit. Note that if NO had been required for exercise coronary vasodilation, the slope of coronary blood flow versus myocardial oxygen consumption would have been reduced and not increased, as was observed. Systemic administration of L-NNA in the present study resulted in a significant increase in mean aortic pressure (Figure 1C) and a significant decrease in heart rate (Figure 1B), consistent with previous studies.^{2 9 11}

View larger version (19K): [in this window] [in a new window]   Figure 1. Slope of coronary blood flow vs myocardial oxygen consumption was significantly increased by NO synthesis inhibition (multiple linear regression, P=0.01), which was due to lower hematocrit after L-NNA treatment. If NO were required for exercise coronary vasodilation, the slope of this relationship would have decreased, not increased. Average mean aortic pressure was significantly increased (ANCOVA, P<0.001) by inhibition of NO synthesis in peripheral vessels, which resulted in a significant reflex reduction in heart rate (ANCOVA, P<0.001).

The relationship between myocardial oxygen consumption and coronary venous oxygen tension is shown in Figure 2. The slope of the coronary venous oxygen tension versus myocardial oxygen consumption was not significantly altered by L-NNA, demonstrating that NO is not required for exercise-induced coronary vasodilation. However, the average coronary venous oxygen tension was decreased by L-NNA (P=0.004), indicating that NO contributes to coronary vasodilation at rest and during exercise.

View larger version (25K): [in this window] [in a new window]   Figure 2. Slope of coronary venous oxygen tension vs myocardial oxygen consumption was unchanged by inhibition of NO synthesis (multiple linear regression, P=0.79), indicating that NO does not act as a local metabolic vasodilator during exercise. Average coronary venous oxygen tension was significantly reduced by L-NNA (ANCOVA, P=0.004), indicating that NO contributes to control of coronary blood flow at rest and during exercise.

The arterial plasma adenosine concentration was not significantly altered by increased myocardial oxygen consumption or by L-NNA (Figure 3A). During control and L-NNA treatment, coronary venous plasma adenosine and estimated interstitial adenosine concentrations were changed little during exercise (Figures 3B and 4). The slopes of these relationships were not significantly different between control and L-NNA treatment, and the common slope did not differ significantly from zero. The estimated interstitial adenosine concentration remained well below the 117 nmol/L threshold concentration necessary for coronary vasodilation.²⁰ These findings demonstrate that adenosine does not compensate for the loss of vasodilation when NO synthesis is inhibited.

View larger version (19K): [in this window] [in a new window]   Figure 3. A, Arterial plasma adenosine concentration was unchanged throughout experimental protocol. Slopes of coronary venous plasma adenosine concentration vs myocardial oxygen consumption did not significantly differ from each other (multiple linear regression, P=0.93), and average slope did not differ significantly from zero (multiple linear regression, P=0.35). B, Average coronary venous plasma adenosine concentration was not elevated by NO synthesis inhibition (ANCOVA, P=0.39), indicating that adenosine levels do not increase to compensate for loss of NO.

View larger version (29K): [in this window] [in a new window]   Figure 4. Relationship between estimated interstitial adenosine concentration and myocardial oxygen consumption during control vehicle and during NO synthesis inhibition with L-NNA. Slopes of the relationship did not differ significantly from each other (multiple linear regression, P=0.98), and average slope did not differ significantly from zero (multiple linear regression, P=0.22). Average value of estimated interstitial adenosine concentration was not elevated by NO synthesis inhibition (ANCOVA, P=0.41). Estimated interstitial adenosine concentration remained well below threshold for coronary vasodilation20 for both treatments. This demonstrates that adenosine does not compensate for loss of vasodilation when NO synthesis is inhibited.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
The present study is the first to measure adenosine levels when NO synthesis is inhibited during exercise. Coronary venous plasma and estimated interstitial adenosine concentrations were unaltered by NO synthesis inhibition at rest and when myocardial oxygen consumption was increased 3.7-fold during exercise. Furthermore, the estimated interstitial adenosine concentration remained well below the threshold concentration (117 nmol/L) necessary for coronary vasodilation.²⁰ Therefore, adenosine does not increase to mediate increases in coronary blood flow when NO synthesis is inhibited.

NO and Coronary Blood Flow Regulation
Blockade of NO synthesis did not attenuate exercise coronary vasodilation (Figure 1A) or alter the slope of the relationship between coronary venous oxygen tension and myocardial oxygen consumption (Figure 2). These findings are consistent with previous studies using either systemic^{2 9 11} or intracoronary blockade of NO synthesis^{1 5} and indicate that NO is not required for exercise coronary vasodilation but does contribute to the control of coronary blood flow at rest and during exercise.

Stamler et al²³ recently proposed that nitrosohemoglobin may serve as an NO donor and potentially mediate increases in coronary blood flow. It is unlikely that NO released from nitrosohemoglobin played a significant role in coronary flow regulation in the present study because Bernstein et al² found that NO production in the coronary circulation was significantly impaired by the same dose of L-NNA used in the present study. However, the exact role of nitrosohemoglobin in coronary blood flow control merits further research.

Studies have also shown that NO may have an inhibitory effect on tissue oxygen consumption.^{2 24} Bernstein et al² reported that systemic administration of L-NNA did not significantly alter myocardial oxygen consumption relative to control but did increase myocardial oxygen consumption at a given level of cardiac work. The experimental design of the present study does not test the hypothesis of Bernstein et al.

Effect of NO on Epicardial Coronary Diameter
NO has been shown to contribute to epicardial coronary dilation at rest in dogs^{25 26 27 28 29} and humans^{30 31} and during increases in myocardial oxygen consumption in dogs^{3 11 13 32} and humans.^{12 33} This effect of NO is demonstrated by a reduction in epicardial coronary diameter when NO synthesis is inhibited, but with little or no change in coronary blood flow. Jones et al³⁴ reported that inhibition of NO synthesis not only resulted in epicardial coronary constriction but also a compensatory arteriolar coronary dilation.

The findings of Bernstein et al² suggest that exercise-induced epicardial coronary dilation is mediated by an increase in cardiac NO production. Increased NO production when myocardial oxygen consumption is elevated is probably due to the increases in shear stress that result from the higher coronary flow rates. This is supported by the findings of Van Bibber et al,³⁵ who found that inhibition of NO synthesis attenuated norepinephrine-induced coronary vasodilation when coronary pressure was held constant but did not affect the coronary vasodilation to norepinephrine when coronary blood flow was held constant.

Role of Adenosine After Inhibition of NO Synthesis
There are multiple mechanisms responsible for local metabolic control of coronary blood flow.⁶ There is also the suggestion that when one mechanism is inhibited, another may increase in compensation.^{6 15 18} The present study was specifically designed to test whether adenosine increases to mediate coronary vasodilation when NO synthesis is inhibited during exercise. Neither coronary venous plasma nor estimated interstitial adenosine concentrations were altered when NO synthesis was inhibited at rest or when oxygen consumption was increased 3.7-fold during exercise (Figures 3B and 4). Furthermore, the estimated interstitial adenosine concentration remained well below the 117 nmol/L threshold value necessary for coronary vasodilation.²⁰ The present results indicate that adenosine does not compensate for the loss of vasodilation by mediating the local metabolic control of coronary blood flow when NO synthesis is inhibited. However, the possibility of compensation by other vasoregulatory agents is not ruled out.

The present findings are also consistent with an earlier study by Tune et al²¹ in that coronary venous adenosine concentration was changed little with exercise and the estimated interstitial adenosine concentration remained well below the threshold for coronary vasodilation. These results indicate that adenosine is not responsible for local metabolic control of coronary blood flow.

The methods used in the present investigation are capable of detecting the elevations in coronary venous adenosine concentration that occur during hypoxia,³⁶ coronary autoregulation,³⁷ intracoronary norepinephrine infusion,³⁸ and the release of endogenous adenosine by inhibiting adenosine kinase and adenosine deaminase.²⁰ Therefore, it is very likely that the present methods are adequate for detecting significant changes in coronary venous plasma adenosine concentration during exercise. Furthermore, the studies cited above demonstrate that increases in cardiac interstitial adenosine concentration are reflected in coronary venous adenosine concentration despite avid uptake of adenosine by coronary vascular endothelium.^{19 39}

In contrast to the present study, Minamino et al¹⁷ reported that coronary venous adenosine concentration increased with time during continuous intracoronary infusion of the NO synthesis inhibitor N-nitro-L-arginine methyl ester (L-NAME) in open-chest dogs. In the Minamino study, coronary blood flow was unaltered by L-NAME infusion and was also unchanged when the adenosine receptor antagonist 8-sulfophenyltheophylline was combined with L-NAME, which argues against a compensatory adenosine vasodilation.

Matsunaga et al¹⁵ found that the rate of adenosine release was increased when myocardial oxygen consumption was increased 20% by atrial pacing in anesthetized dogs pretreated with the NO synthesis inhibitor L-NAME. Tayama et al¹⁸ observed that chronic 4-week administration of dietary L-NAME resulted in an increase in cardiac adenosine release in a terminal open-chest canine experiment. The release rate is calculated by multiplying coronary flow by the difference in arterial and coronary venous adenosine concentration. A major problem with release rates is that an increase in coronary blood flow or a decrease in arterial adenosine concentration can result in an increase in adenosine release with no change in coronary venous adenosine concentration. The concentration of adenosine in the coronary venous plasma has been shown to be a sensitive indicator of cardiac interstitial adenosine levels.^{19 20} Therefore, reporting only the release rate of adenosine offers little quantitative information on the relationship between interstitial adenosine concentration and coronary blood flow.

Adenosine receptor blockade has also been used in combination with NO synthesis inhibition to determine whether adenosine mediates local metabolic coronary vasodilation when NO synthesis is inhibited. In 3 studies, the results with adenosine receptor blockade after prior inhibition of NO synthesis did not indicate compensation by adenosine.^{6 14 17} In 2 studies, the results were interpreted to mean that adenosine receptor blockade demonstrated a role for adenosine after NO synthesis inhibition.^{15 18} However, a replotting of the data from all 5 of these studies is consistent in that the relation between coronary blood flow and myocardial oxygen consumption is not changed by adenosine blockade after prior NO synthesis inhibition.

Physiological Role of NO in the Coronary Circulation
In summary, blockade of NO synthesis decreases coronary venous oxygen tension but does not steepen the relationship between coronary venous oxygen tension and myocardial oxygen consumption. Therefore, NO does not act as a local metabolic vasodilator in the usual sense. Furthermore, when NO synthesis is inhibited, adenosine levels do not increase in compensation. However, NO has meaningful physiological effects within the coronary vascular tree, notably, the upstream dilation of epicardial coronary arteries, which prevents excessive shear stress on the endothelium when flow is increased by downstream vasodilation.

	Acknowledgments

 
This study was supported by National Institutes of Health grants HL-49822, HL-49170, RR-01243, and HL-07403. We thank Pamela Campbell for expert technical and editorial assistance in all phases of this research.

Received August 18, 1999; revision received January 21, 2000; accepted January 31, 2000.

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Altman JD, Kinn J, Duncker DJ, et al. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res. 1994;28:119–124.[Abstract/Free Full Text]
   
2. Bernstein RD, Ochoa FY, Xu X, et al. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res. 1996;79:840–848.[Abstract/Free Full Text]
   
3. Canty JM Jr, Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation. 1994;89:375–384.[Abstract/Free Full Text]
   
4. Davis CAI, Sherman AJ, Yaroshenko Y, et al. Coronary vascular responsiveness to adenosine is impaired additively by blockade of nitric oxide synthesis and a sulfonylurea. J Am Coll Cardiol. 1998;31:816–822.[Abstract/Free Full Text]
   
5. Duncker DJ, Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Circ Res. 1994;74:629–640.[Abstract/Free Full Text]
   
6. Ishibashi Y, Duncker DJ, Zhang J, et al. ATP-sensitive K⁺ channels, adenosine, and nitric oxide–mediated mechanisms account for coronary vasodilation during exercise. Circ Res. 1998;82:346–359.[Abstract/Free Full Text]
   
7. Parent R, Al-Obaidi M, Lavallée M. Nitric oxide formation contributes to ß-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res. 1993;73:241–251.[Abstract/Free Full Text]
   
8. Parent R, Paré R, Lavallée M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol. 1992;262:H10–H16.[Abstract/Free Full Text]
   
9. Shen W, Lundborg M, Wang J, et al. Role of EDRF in the regulation of regional blood flow and vascular resistance at rest and during exercise in conscious dog. J Appl Physiol. 1994;77:165–172.[Abstract/Free Full Text]
   
10. Smith TP Jr, Canty JM Jr. Modulation of coronary autoregulatory responses by nitric oxide: evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res. 1993;73:232–240.[Abstract/Free Full Text]
    
11. Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res. 1993;73:829–838.[Abstract/Free Full Text]
    
12. Egashira K, Katsuda Y, Mohri M, et al. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res. 1996;79:331–335.[Abstract/Free Full Text]
    
13. Embrey RP, Brooks LA, Dellsperger KC. Mechanism of coronary microvascular responses to metabolic stimulation. Cardiovasc Res. 1997;35:148–157.[Abstract/Free Full Text]
    
14. Maekawa K, Saito D, Obayashi N, et al. Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia. Am J Physiol. 1994;267:H166–H173.[Abstract/Free Full Text]
    
15. Matsunaga T, Okumura K, Tsunoda R, et al. Role of adenosine in regulation of coronary flow in dogs with inhibited synthesis of endothelium-derived nitric oxide. Am J Physiol. 1996;270:H427–H434.[Abstract/Free Full Text]
    
16. Nishikawa Y, Kanki H, Ogawa S. Role of nitric oxide in coronary vasomotion during handgrip exercise. Am Heart J. 1997;134:967–973.[Medline] [Order article via Infotrieve]
    
17. Minamino T, Kitakaze M, Node K, et al. Inhibition of nitric oxide synthesis increases adenosine production via an extracellular pathway through activation of protein kinase C. Circulation. 1997;96:1586–1592.[Abstract/Free Full Text]
    
18. Tayama S, Okumura K, Matsunaga T, et al. Influence of chronic nitric oxide inhibition of coronary blood flow regulation: a study of the role of endogenous adenosine in anesthetized, open-chest dogs. Jpn Circ J. 1998;62:371–378.[Medline] [Order article via Infotrieve]
    
19. Kroll K, Stepp DW. Adenosine kinetics in the canine coronary circulation. Am J Physiol. 1996;270:H1469–H1483.[Abstract/Free Full Text]
    
20. Stepp DW, Van Bibber R, Kroll K, et al. Quantitative relation between interstitial adenosine concentration and coronary blood flow. Circ Res. 1996;79:601–610.[Abstract/Free Full Text]
    
21. Tune JD, Richmond KN, Gorman MW, et al. Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise. Am J Physiol. 2000; 278:H74–H84.
    
22. Kroll K, Deussen A, Sweet IR. Comprehensive model of transport and metabolism of adenosine and S-adenosylhomocysteine in the guinea pig heart. Circ Res. 1992;71:590–604.[Abstract/Free Full Text]
    
23. Stamler JS, Jia L, Eu JP, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276:2034–2037.[Abstract/Free Full Text]
    
24. Shen W, Xu X, Ochoa M, et al. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 1994;75:1086–1095.[Abstract/Free Full Text]
    
25. Chu A, Chambers DE, Lin C-C, et al. Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. Am J Physiol. 1990;258:H1250–H1254.[Abstract/Free Full Text]
    
26. Chu A, Chambers DE, Lin C-C, et al. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest. 1991;87:1964–1968.
    
27. Hamdad N, Ming Z, Parent R, et al. ß₂-Adrenergic dilation of conductance coronary arteries involves flow-dependent NO formation in conscious dogs. Am J Physiol. 1996;271:H1926–H1937.[Abstract/Free Full Text]
    
28. Jones CJH, DeFily DV, Patterson JL, et al. Endothelium-dependent relaxation competes with ₁- and ₂-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation. 1993;87:1264–1274.[Abstract/Free Full Text]
    
29. Parent R, Hamdad N, Ming Z, et al. Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs. Cardiovasc Res. 1996;31:555–567.[Medline] [Order article via Infotrieve]
    
30. Lefroy DC, Crake T, Uren NG, et al. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation. 1993;88:43–54.[Abstract/Free Full Text]
    
31. Nishikawa Y, Ogawa S. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. J Am Coll Cardiol. 1997;29:85–92.[Abstract]
    
32. Berdeaux A, Ghaleh B, Dubois-Randé JL, et al. Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Circulation. 1994;89:2799–2808.[Abstract/Free Full Text]
    
33. Quyyumi AA, Dakak N, Andrews NP, et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995;92:320–326.[Abstract/Free Full Text]
    
34. Jones CJH, Kuo L, Davis MJ, et al. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation. 1995;91:1807–1813.[Abstract/Free Full Text]
    
35. Van Bibber R, Traub O, Kroll K, et al. EDRF and norepinephrine-induced coronary vasodilation in the canine coronary circulation. Am J Physiol. 1995;268:H1973–H1981.[Abstract/Free Full Text]
    
36. Herrmann SC, Feigl EO. Adrenergic blockade blunts adenosine concentration and coronary vasodilation during hypoxia. Circ Res. 1992;70:1203–1216.[Abstract/Free Full Text]
    
37. Stepp DW, Kroll K, Feigl EO. K⁺_ATP channels and adenosine are not necessary for coronary autoregulation. Am J Physiol. 1997;273:H1299–H1308.[Abstract/Free Full Text]
    
38. Van Bibber R, Stepp DW, Kroll K, et al. The role of adenosine in norepinephrine-induced coronary vasodilation. Am J Physiol. 1997;273:H557–H565.[Abstract/Free Full Text]
    
39. Nees S, Herzog V, Becker BF, et al. The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol. 1985;80:515–529.[Medline] [Order article via Infotrieve]
    

This article has been cited by other articles:

				D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF]

				B. A. Kaufmann, A. M. Bernheim, S. Kiencke, M. Fischler, J. Sklenar, H. Mairbaurl, M. Maggiorini, and H. P. Brunner-La Rocca Evidence supportive of impaired myocardial blood flow reserve at high altitude in subjects developing high-altitude pulmonary edema Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1651 - H1657. [Abstract] [Full Text] [PDF]

				R. M. McAllister, S. C. Newcomer, E. R. Pope, J. R. Turk, and M. H. Laughlin Effects of chronic nitric oxide synthase inhibition on responses to acute exercise in swine J Appl Physiol, January 1, 2008; 104(1): 186 - 197. [Abstract] [Full Text] [PDF]

				D. J. Duncker and D. Merkus Exercise hyperaemia in the heart: the search for the dilator mechanism J. Physiol., September 15, 2007; 583(3): 847 - 854. [Abstract] [Full Text] [PDF]

				D. Merkus, O. Sorop, B. Houweling, F. Boomsma, A. H. van den Meiracker, and D. J. Duncker NO and prostanoids blunt endothelin-mediated coronary vasoconstrictor influence in exercising swine Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2075 - H2081. [Abstract] [Full Text] [PDF]

				X. Monnet, B. Ghaleh, L. Lucats, P. Colin, R. Zini, L. Hittinger, and A. Berdeaux Phenotypic adaptation of the late preconditioned heart: Myocardial oxygen consumption is reduced Cardiovasc Res, May 1, 2006; 70(2): 391 - 398. [Abstract] [Full Text] [PDF]

				P. Zong, J. D. Tune, and H. F. Downey Mechanisms of Oxygen Demand/Supply Balance in the Right Ventricle Experimental Biology and Medicine, September 1, 2005; 230(8): 507 - 519. [Abstract] [Full Text] [PDF]

				X. Zhao, G. He, Y.-R. Chen, R. P. Pandian, P. Kuppusamy, and J. L. Zweier Endothelium-Derived Nitric Oxide Regulates Postischemic Myocardial Oxygenation and Oxygen Consumption by Modulation of Mitochondrial Electron Transport Circulation, June 7, 2005; 111(22): 2966 - 2972. [Abstract] [Full Text] [PDF]

				R. R. Martinez, S. Setty, P. Zong, J. D. Tune, and H. F. Downey Nitric oxide contributes to right coronary vasodilation during systemic hypoxia Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1139 - H1146. [Abstract] [Full Text] [PDF]

				S. Setty, J. D. Tune, and H. F. Downey Nitric oxide contributes to oxygen demand-supply balance in hypoperfused right ventricle Cardiovasc Res, December 1, 2004; 64(3): 431 - 436. [Abstract] [Full Text] [PDF]

				J. D. Tune, M. W. Gorman, and E. O. Feigl Matching coronary blood flow to myocardial oxygen consumption J Appl Physiol, July 1, 2004; 97(1): 404 - 415. [Abstract] [Full Text] [PDF]

				S. Setty, W. Sun, R. Martinez, H. F. Downey, and J. D. Tune {alpha}-Adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus J Appl Physiol, July 1, 2004; 97(1): 431 - 438. [Abstract] [Full Text] [PDF]

				J. B. Rosenmeier, J. Hansen, and J. Gonzalez-Alonso Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle J. Physiol., July 1, 2004; 558(1): 351 - 365. [Abstract] [Full Text] [PDF]

				P. Zong, W. Sun, S. Setty, J. D. Tune, and H. F. Downey {alpha}-Adrenergic Vasoconstrictor Tone Limits Right Coronary Blood Flow in Exercising Dogs Experimental Biology and Medicine, April 1, 2004; 229(4): 312 - 322. [Abstract] [Full Text] [PDF]

				D. Merkus, D. B. Haitsma, T.-Y. Fung, Y. J. Assen, P. D. Verdouw, and D. J. Duncker Coronary blood flow regulation in exercising swine involves parallel rather than redundant vasodilator pathways Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H424 - H433. [Abstract] [Full Text] [PDF]

				M. Okajima, M. Takamura, P. Vequaud, R. Parent, and M. Lavallee beta -Adrenergic receptor blockade impairs NO-dependent dilation of large coronary arteries during exercise Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H501 - H510. [Abstract] [Full Text] [PDF]

				J. D. Tune, K. N. Richmond, M. W. Gorman, and E. O. Feigl Control of Coronary Blood Flow during Exercise Experimental Biology and Medicine, April 1, 2002; 227(4): 238 - 250. [Abstract] [Full Text] [PDF]

				B. J. Hart, X. Bian, P. A. Gwirtz, S. Setty, and H. F. Downey Right ventricular oxygen supply/demand balance in exercising dogs Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H823 - H830. [Abstract] [Full Text] [PDF]

				S. Setty, X. Bian, J. D. Tune, and H. F. Downey Endogenous nitric oxide modulates myocardial oxygen consumption in canine right ventricle Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H831 - H837. [Abstract] [Full Text] [PDF]

				J. D. Tune, K. N. Richmond, M. W. Gorman, and E. O. Feigl KATP+ channels, nitric oxide, and adenosine are not required for local metabolic coronary vasodilation Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H868 - H875. [Abstract] [Full Text] [PDF]

				S. Setty, J. D. Tune, and H. F. Downey Nitric oxide modulates right ventricular flow and oxygen consumption during norepinephrine infusion Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H696 - H703. [Abstract] [Full Text] [PDF]

				M. Takamura, R. Parent, and M. Lavallee Enhanced contribution of NO to exercise-induced coronary responses after alpha -adrenergic receptor blockade Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H508 - H515. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire